Viridian Therapeutics
VRDN
#4802
Rank
S$2.04 B
Marketcap
$25.82
Share price
1.60%
Change (1 day)
-13.24%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$6.61

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.61. In 2022 the company made an earnings per share (EPS) of -$5.47 an increase over its 2021 EPS that were of -$10.28.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.6120.82%
2022-$5.47-46.83%
2021-$10.28-73.94%
2020-$39.4744.73%
2019-$27.2722.94%
2018-$22.18-27.33%
2017-$30.53-91.47%
2016-$357.77-19.17%
2015-$442.63-75.48%
2014-$1,805582.47%
2013-$264.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.96-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA